Index by author
August 01, 1996; Volume 50,Issue 2
A
Ahmad, S
- You have accessTreatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.T Yazaki, S Ahmad, A Chahlavi, E Zylber-Katz, N M Dean, S D Rabkin, R L Martuza and R I GlazerMolecular Pharmacology August 1996, 50 (2) 236-242;
Akhtar, S
- You have accessA nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.J M Coulson, D R Poyner, A Chantry, W J Irwin and S AkhtarMolecular Pharmacology August 1996, 50 (2) 314-325;
Alzola, E S
- You have accessThrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.F J Azula, E S Alzola, M Conde, M Trueba, J M Macarulla and A MarinoMolecular Pharmacology August 1996, 50 (2) 367-379;
André, C
- You have accessTienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9.S Lecoeur, C André and P H BeauneMolecular Pharmacology August 1996, 50 (2) 326-333;
Aquaro, S
- You have accessPotent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.C F Perno, E Balestra, S Aquaro, S Panti, A Cenci, G Lazzarino, B Tavazzi, D Di Pierro, J Balzarini and R CalioMolecular Pharmacology August 1996, 50 (2) 359-366;
- You have accessHighly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.J Balzarini, H Pelemans, S Aquaro, C F Perno, M Witvrouw, D Schols, E De Clercq and A KarlssonMolecular Pharmacology August 1996, 50 (2) 394-401;
Azula, F J
- You have accessThrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.F J Azula, E S Alzola, M Conde, M Trueba, J M Macarulla and A MarinoMolecular Pharmacology August 1996, 50 (2) 367-379;
B
Backlund, M
- You have accessCytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene.E Hedlund, A Wyss, T Kainu, M Backlund, C Köhler, M Pelto-Huikko, J A Gustafsson and M WarnerMolecular Pharmacology August 1996, 50 (2) 342-350;
Balestra, E
- You have accessPotent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.C F Perno, E Balestra, S Aquaro, S Panti, A Cenci, G Lazzarino, B Tavazzi, D Di Pierro, J Balzarini and R CalioMolecular Pharmacology August 1996, 50 (2) 359-366;
Balzarini, J
- You have accessPotent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.C F Perno, E Balestra, S Aquaro, S Panti, A Cenci, G Lazzarino, B Tavazzi, D Di Pierro, J Balzarini and R CalioMolecular Pharmacology August 1996, 50 (2) 359-366;
- You have accessHighly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.J Balzarini, H Pelemans, S Aquaro, C F Perno, M Witvrouw, D Schols, E De Clercq and A KarlssonMolecular Pharmacology August 1996, 50 (2) 394-401;
Barnard, E A
- You have accessA novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates.T E Webb, D Henderson, B F King, S Wang, J Simon, A N Bateson, G Burnstock and E A BarnardMolecular Pharmacology August 1996, 50 (2) 258-265;
Bateson, A N
- You have accessA novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates.T E Webb, D Henderson, B F King, S Wang, J Simon, A N Bateson, G Burnstock and E A BarnardMolecular Pharmacology August 1996, 50 (2) 258-265;
Beaune, P H
- You have accessTienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9.S Lecoeur, C André and P H BeauneMolecular Pharmacology August 1996, 50 (2) 326-333;
Beck-Sickinger, A G
- You have accessNeuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.M Sautel, K Rudolf, H Wittneben, H Herzog, R Martinez, M Munoz, W Eberlein, W Engel, P Walker and A G Beck-SickingerMolecular Pharmacology August 1996, 50 (2) 285-292;
Beinborn, M
- You have accessIdentification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.F Schmitz, D S Pratt, M J Wu, L F Kolakowski, M Beinborn and A S KopinMolecular Pharmacology August 1996, 50 (2) 436-441;
Beindl, W
- You have accessInhibition of receptor/G protein coupling by suramin analogues.W Beindl, T Mitterauer, M Hohenegger, A P Ijzerman, C Nanoff and M FreissmuthMolecular Pharmacology August 1996, 50 (2) 415-423;
Bell, G I
- You have accessLeptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus.S R Glaum, M Hara, V P Bindokas, C C Lee, K S Polonsky, G I Bell and R J MillerMolecular Pharmacology August 1996, 50 (2) 230-235;
Berry, S A
- You have accessRapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro.S A Berry, M C Shah, N Khan and B L RothMolecular Pharmacology August 1996, 50 (2) 306-313;
Billings, R E
- You have accessCharacterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants.D L Duval, D R Miller, J Collier and R E BillingsMolecular Pharmacology August 1996, 50 (2) 277-284;
Bindokas, V P
- You have accessLeptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus.S R Glaum, M Hara, V P Bindokas, C C Lee, K S Polonsky, G I Bell and R J MillerMolecular Pharmacology August 1996, 50 (2) 230-235;
Blakely, R D
- You have accessInability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.H E Melikian, S Ramamoorthy, C G Tate and R D BlakelyMolecular Pharmacology August 1996, 50 (2) 266-276;
Bogatkewitsch, G S
- You have accessReceptor internalization delays m4 muscarinic acetylcholine receptor resensitization at the plasma membrane.G S Bogatkewitsch, W Lenz, K H Jakobs and C J Van KoppenMolecular Pharmacology August 1996, 50 (2) 424-429;
Bouchelet, I
- You have accessDifferential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels.I Bouchelet, Z Cohen, B Case, P Séguéla and E HamelMolecular Pharmacology August 1996, 50 (2) 219-223;
Brown, A M
- You have accessMapping the block of a cloned human inward rectifier potassium channel by dofetilide.J Kiehn, B Wible, A E Lacerda and A M BrownMolecular Pharmacology August 1996, 50 (2) 380-387;
Burnstock, G
- You have accessA novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates.T E Webb, D Henderson, B F King, S Wang, J Simon, A N Bateson, G Burnstock and E A BarnardMolecular Pharmacology August 1996, 50 (2) 258-265;
C
Calio, R
- You have accessPotent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.C F Perno, E Balestra, S Aquaro, S Panti, A Cenci, G Lazzarino, B Tavazzi, D Di Pierro, J Balzarini and R CalioMolecular Pharmacology August 1996, 50 (2) 359-366;
Case, B
- You have accessDifferential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels.I Bouchelet, Z Cohen, B Case, P Séguéla and E HamelMolecular Pharmacology August 1996, 50 (2) 219-223;
Cass, C E
- You have accessTransport of the antiviral nucleoside analogs 3'-azido-3'-deoxythymidine and 2',3'-dideoxycytidine by a recombinant nucleoside transporter (rCNT) expressed in Xenopus laevis oocytes.S Y Yao, C E Cass and J D YoungMolecular Pharmacology August 1996, 50 (2) 388-393;
Cenci, A
- You have accessPotent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.C F Perno, E Balestra, S Aquaro, S Panti, A Cenci, G Lazzarino, B Tavazzi, D Di Pierro, J Balzarini and R CalioMolecular Pharmacology August 1996, 50 (2) 359-366;
Chahlavi, A
- You have accessTreatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.T Yazaki, S Ahmad, A Chahlavi, E Zylber-Katz, N M Dean, S D Rabkin, R L Martuza and R I GlazerMolecular Pharmacology August 1996, 50 (2) 236-242;
Chantry, A
- You have accessA nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.J M Coulson, D R Poyner, A Chantry, W J Irwin and S AkhtarMolecular Pharmacology August 1996, 50 (2) 314-325;
Cohen, Z
- You have accessDifferential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels.I Bouchelet, Z Cohen, B Case, P Séguéla and E HamelMolecular Pharmacology August 1996, 50 (2) 219-223;
Collier, J
- You have accessCharacterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants.D L Duval, D R Miller, J Collier and R E BillingsMolecular Pharmacology August 1996, 50 (2) 277-284;
Conde, M
- You have accessThrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.F J Azula, E S Alzola, M Conde, M Trueba, J M Macarulla and A MarinoMolecular Pharmacology August 1996, 50 (2) 367-379;
Constantinou, A
- You have accessResistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.R Ganapathi, A Constantinou, N Kamath, G Dubyak, D Grabowski and K KrivacicMolecular Pharmacology August 1996, 50 (2) 243-248;
Coulson, J M
- You have accessA nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.J M Coulson, D R Poyner, A Chantry, W J Irwin and S AkhtarMolecular Pharmacology August 1996, 50 (2) 314-325;
D
Dalman, H M
- You have accessStructural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region.S M Wade, M K Scribner, H M Dalman, J M Taylor and R R NeubigMolecular Pharmacology August 1996, 50 (2) 351-358;
Dean, N M
- You have accessTreatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.T Yazaki, S Ahmad, A Chahlavi, E Zylber-Katz, N M Dean, S D Rabkin, R L Martuza and R I GlazerMolecular Pharmacology August 1996, 50 (2) 236-242;
De Clercq, E
- You have accessHighly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.J Balzarini, H Pelemans, S Aquaro, C F Perno, M Witvrouw, D Schols, E De Clercq and A KarlssonMolecular Pharmacology August 1996, 50 (2) 394-401;
Di Pierro, D
- You have accessPotent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.C F Perno, E Balestra, S Aquaro, S Panti, A Cenci, G Lazzarino, B Tavazzi, D Di Pierro, J Balzarini and R CalioMolecular Pharmacology August 1996, 50 (2) 359-366;
Drewett, J G
- You have accessNovel natriuretic peptide receptor/guanylyl cyclase A-selective agonist inhibits angiotensin II- and forskolin-evoked aldosterone synthesis in a human zona glomerulosa cell line.L J Olson, D G Lowe and J G DrewettMolecular Pharmacology August 1996, 50 (2) 430-435;
Dubyak, G
- You have accessResistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.R Ganapathi, A Constantinou, N Kamath, G Dubyak, D Grabowski and K KrivacicMolecular Pharmacology August 1996, 50 (2) 243-248;
Duval, D L
- You have accessCharacterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants.D L Duval, D R Miller, J Collier and R E BillingsMolecular Pharmacology August 1996, 50 (2) 277-284;
E
Eberlein, W
- You have accessNeuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.M Sautel, K Rudolf, H Wittneben, H Herzog, R Martinez, M Munoz, W Eberlein, W Engel, P Walker and A G Beck-SickingerMolecular Pharmacology August 1996, 50 (2) 285-292;
Engel, W
- You have accessNeuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.M Sautel, K Rudolf, H Wittneben, H Herzog, R Martinez, M Munoz, W Eberlein, W Engel, P Walker and A G Beck-SickingerMolecular Pharmacology August 1996, 50 (2) 285-292;
F
Freissmuth, M
- You have accessInhibition of receptor/G protein coupling by suramin analogues.W Beindl, T Mitterauer, M Hohenegger, A P Ijzerman, C Nanoff and M FreissmuthMolecular Pharmacology August 1996, 50 (2) 415-423;
G
Ganapathi, R
- You have accessResistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.R Ganapathi, A Constantinou, N Kamath, G Dubyak, D Grabowski and K KrivacicMolecular Pharmacology August 1996, 50 (2) 243-248;
Gesek, F A
- You have accessAlpha 2-adrenergic receptors activate phospholipase C in renal epithelial cells.F A GesekMolecular Pharmacology August 1996, 50 (2) 407-414;
Glaum, S R
- You have accessLeptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus.S R Glaum, M Hara, V P Bindokas, C C Lee, K S Polonsky, G I Bell and R J MillerMolecular Pharmacology August 1996, 50 (2) 230-235;
Glazer, R I
- You have accessTreatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.T Yazaki, S Ahmad, A Chahlavi, E Zylber-Katz, N M Dean, S D Rabkin, R L Martuza and R I GlazerMolecular Pharmacology August 1996, 50 (2) 236-242;
Grabowski, D
- You have accessResistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.R Ganapathi, A Constantinou, N Kamath, G Dubyak, D Grabowski and K KrivacicMolecular Pharmacology August 1996, 50 (2) 243-248;
Gustafsson, J A
- You have accessCytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene.E Hedlund, A Wyss, T Kainu, M Backlund, C Köhler, M Pelto-Huikko, J A Gustafsson and M WarnerMolecular Pharmacology August 1996, 50 (2) 342-350;
H
Hamel, E
- You have accessDifferential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels.I Bouchelet, Z Cohen, B Case, P Séguéla and E HamelMolecular Pharmacology August 1996, 50 (2) 219-223;
Hara, M
- You have accessLeptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus.S R Glaum, M Hara, V P Bindokas, C C Lee, K S Polonsky, G I Bell and R J MillerMolecular Pharmacology August 1996, 50 (2) 230-235;
Harden, K
- You have accessUridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.R A Nicholas, W C Watt, E R Lazarowski, Q Li and K HardenMolecular Pharmacology August 1996, 50 (2) 224-229;
Harris, R A
- You have accessA single amino acid determines differences in ethanol actions on strychnine-sensitive glycine receptors.M P Mascia, S J Mihic, C F Valenzuela, P R Schofield and R A HarrisMolecular Pharmacology August 1996, 50 (2) 402-406;
Hedlund, E
- You have accessCytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene.E Hedlund, A Wyss, T Kainu, M Backlund, C Köhler, M Pelto-Huikko, J A Gustafsson and M WarnerMolecular Pharmacology August 1996, 50 (2) 342-350;
Henderson, D
- You have accessA novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates.T E Webb, D Henderson, B F King, S Wang, J Simon, A N Bateson, G Burnstock and E A BarnardMolecular Pharmacology August 1996, 50 (2) 258-265;
Herzog, H
- You have accessNeuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.M Sautel, K Rudolf, H Wittneben, H Herzog, R Martinez, M Munoz, W Eberlein, W Engel, P Walker and A G Beck-SickingerMolecular Pharmacology August 1996, 50 (2) 285-292;
Hohenegger, M
- You have accessInhibition of receptor/G protein coupling by suramin analogues.W Beindl, T Mitterauer, M Hohenegger, A P Ijzerman, C Nanoff and M FreissmuthMolecular Pharmacology August 1996, 50 (2) 415-423;
I
Ijzerman, A P
- You have accessInhibition of receptor/G protein coupling by suramin analogues.W Beindl, T Mitterauer, M Hohenegger, A P Ijzerman, C Nanoff and M FreissmuthMolecular Pharmacology August 1996, 50 (2) 415-423;
Irwin, W J
- You have accessA nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.J M Coulson, D R Poyner, A Chantry, W J Irwin and S AkhtarMolecular Pharmacology August 1996, 50 (2) 314-325;
J
Jakobs, K H
- You have accessReceptor internalization delays m4 muscarinic acetylcholine receptor resensitization at the plasma membrane.G S Bogatkewitsch, W Lenz, K H Jakobs and C J Van KoppenMolecular Pharmacology August 1996, 50 (2) 424-429;
Jeon, Y J
- You have accessAttenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.Y J Jeon, K H Yang, J T Pulaski and N E KaminskiMolecular Pharmacology August 1996, 50 (2) 334-341;
K
Kainu, T
- You have accessCytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene.E Hedlund, A Wyss, T Kainu, M Backlund, C Köhler, M Pelto-Huikko, J A Gustafsson and M WarnerMolecular Pharmacology August 1996, 50 (2) 342-350;
Kamath, N
- You have accessResistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.R Ganapathi, A Constantinou, N Kamath, G Dubyak, D Grabowski and K KrivacicMolecular Pharmacology August 1996, 50 (2) 243-248;
Kaminski, N E
- You have accessAttenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.Y J Jeon, K H Yang, J T Pulaski and N E KaminskiMolecular Pharmacology August 1996, 50 (2) 334-341;
Karlsson, A
- You have accessHighly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.J Balzarini, H Pelemans, S Aquaro, C F Perno, M Witvrouw, D Schols, E De Clercq and A KarlssonMolecular Pharmacology August 1996, 50 (2) 394-401;
Khan, N
- You have accessRapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro.S A Berry, M C Shah, N Khan and B L RothMolecular Pharmacology August 1996, 50 (2) 306-313;
Kiehn, J
- You have accessMapping the block of a cloned human inward rectifier potassium channel by dofetilide.J Kiehn, B Wible, A E Lacerda and A M BrownMolecular Pharmacology August 1996, 50 (2) 380-387;
King, B F
- You have accessA novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates.T E Webb, D Henderson, B F King, S Wang, J Simon, A N Bateson, G Burnstock and E A BarnardMolecular Pharmacology August 1996, 50 (2) 258-265;
Köhler, C
- You have accessCytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene.E Hedlund, A Wyss, T Kainu, M Backlund, C Köhler, M Pelto-Huikko, J A Gustafsson and M WarnerMolecular Pharmacology August 1996, 50 (2) 342-350;
Kolakowski, L F
- You have accessIdentification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.F Schmitz, D S Pratt, M J Wu, L F Kolakowski, M Beinborn and A S KopinMolecular Pharmacology August 1996, 50 (2) 436-441;
Kopin, A S
- You have accessIdentification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.F Schmitz, D S Pratt, M J Wu, L F Kolakowski, M Beinborn and A S KopinMolecular Pharmacology August 1996, 50 (2) 436-441;
Krivacic, K
- You have accessResistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.R Ganapathi, A Constantinou, N Kamath, G Dubyak, D Grabowski and K KrivacicMolecular Pharmacology August 1996, 50 (2) 243-248;
L
Lacerda, A E
- You have accessMapping the block of a cloned human inward rectifier potassium channel by dofetilide.J Kiehn, B Wible, A E Lacerda and A M BrownMolecular Pharmacology August 1996, 50 (2) 380-387;
Lazarowski, E R
- You have accessUridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.R A Nicholas, W C Watt, E R Lazarowski, Q Li and K HardenMolecular Pharmacology August 1996, 50 (2) 224-229;
Lazzarino, G
- You have accessPotent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.C F Perno, E Balestra, S Aquaro, S Panti, A Cenci, G Lazzarino, B Tavazzi, D Di Pierro, J Balzarini and R CalioMolecular Pharmacology August 1996, 50 (2) 359-366;
Lecoeur, S
- You have accessTienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9.S Lecoeur, C André and P H BeauneMolecular Pharmacology August 1996, 50 (2) 326-333;
Lee, C C
- You have accessLeptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus.S R Glaum, M Hara, V P Bindokas, C C Lee, K S Polonsky, G I Bell and R J MillerMolecular Pharmacology August 1996, 50 (2) 230-235;
Lenz, W
- You have accessReceptor internalization delays m4 muscarinic acetylcholine receptor resensitization at the plasma membrane.G S Bogatkewitsch, W Lenz, K H Jakobs and C J Van KoppenMolecular Pharmacology August 1996, 50 (2) 424-429;
Li, Q
- You have accessUridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.R A Nicholas, W C Watt, E R Lazarowski, Q Li and K HardenMolecular Pharmacology August 1996, 50 (2) 224-229;
Lowe, D G
- You have accessNovel natriuretic peptide receptor/guanylyl cyclase A-selective agonist inhibits angiotensin II- and forskolin-evoked aldosterone synthesis in a human zona glomerulosa cell line.L J Olson, D G Lowe and J G DrewettMolecular Pharmacology August 1996, 50 (2) 430-435;
M
Macarulla, J M
- You have accessThrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.F J Azula, E S Alzola, M Conde, M Trueba, J M Macarulla and A MarinoMolecular Pharmacology August 1996, 50 (2) 367-379;
Marino, A
- You have accessThrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.F J Azula, E S Alzola, M Conde, M Trueba, J M Macarulla and A MarinoMolecular Pharmacology August 1996, 50 (2) 367-379;
Martinez, R
- You have accessNeuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.M Sautel, K Rudolf, H Wittneben, H Herzog, R Martinez, M Munoz, W Eberlein, W Engel, P Walker and A G Beck-SickingerMolecular Pharmacology August 1996, 50 (2) 285-292;
Martuza, R L
- You have accessTreatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.T Yazaki, S Ahmad, A Chahlavi, E Zylber-Katz, N M Dean, S D Rabkin, R L Martuza and R I GlazerMolecular Pharmacology August 1996, 50 (2) 236-242;
Mascia, M P
- You have accessA single amino acid determines differences in ethanol actions on strychnine-sensitive glycine receptors.M P Mascia, S J Mihic, C F Valenzuela, P R Schofield and R A HarrisMolecular Pharmacology August 1996, 50 (2) 402-406;
Melikian, H E
- You have accessInability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.H E Melikian, S Ramamoorthy, C G Tate and R D BlakelyMolecular Pharmacology August 1996, 50 (2) 266-276;
Mihic, S J
- You have accessA single amino acid determines differences in ethanol actions on strychnine-sensitive glycine receptors.M P Mascia, S J Mihic, C F Valenzuela, P R Schofield and R A HarrisMolecular Pharmacology August 1996, 50 (2) 402-406;
Miller, D R
- You have accessCharacterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants.D L Duval, D R Miller, J Collier and R E BillingsMolecular Pharmacology August 1996, 50 (2) 277-284;
Miller, R J
- You have accessLeptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus.S R Glaum, M Hara, V P Bindokas, C C Lee, K S Polonsky, G I Bell and R J MillerMolecular Pharmacology August 1996, 50 (2) 230-235;
Mitterauer, T
- You have accessInhibition of receptor/G protein coupling by suramin analogues.W Beindl, T Mitterauer, M Hohenegger, A P Ijzerman, C Nanoff and M FreissmuthMolecular Pharmacology August 1996, 50 (2) 415-423;
Munoz, M
- You have accessNeuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.M Sautel, K Rudolf, H Wittneben, H Herzog, R Martinez, M Munoz, W Eberlein, W Engel, P Walker and A G Beck-SickingerMolecular Pharmacology August 1996, 50 (2) 285-292;
N
Nanoff, C
- You have accessInhibition of receptor/G protein coupling by suramin analogues.W Beindl, T Mitterauer, M Hohenegger, A P Ijzerman, C Nanoff and M FreissmuthMolecular Pharmacology August 1996, 50 (2) 415-423;
Neubig, R R
- You have accessStructural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region.S M Wade, M K Scribner, H M Dalman, J M Taylor and R R NeubigMolecular Pharmacology August 1996, 50 (2) 351-358;
Nicholas, R A
- You have accessUridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.R A Nicholas, W C Watt, E R Lazarowski, Q Li and K HardenMolecular Pharmacology August 1996, 50 (2) 224-229;
O
Olson, L J
- You have accessNovel natriuretic peptide receptor/guanylyl cyclase A-selective agonist inhibits angiotensin II- and forskolin-evoked aldosterone synthesis in a human zona glomerulosa cell line.L J Olson, D G Lowe and J G DrewettMolecular Pharmacology August 1996, 50 (2) 430-435;
P
Panti, S
- You have accessPotent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.C F Perno, E Balestra, S Aquaro, S Panti, A Cenci, G Lazzarino, B Tavazzi, D Di Pierro, J Balzarini and R CalioMolecular Pharmacology August 1996, 50 (2) 359-366;
Pasternak, G W
- You have accessDifferential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits.K M Standifer, G C Rossi and G W PasternakMolecular Pharmacology August 1996, 50 (2) 293-298;
Pelemans, H
- You have accessHighly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.J Balzarini, H Pelemans, S Aquaro, C F Perno, M Witvrouw, D Schols, E De Clercq and A KarlssonMolecular Pharmacology August 1996, 50 (2) 394-401;
Pelto-Huikko, M
- You have accessCytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene.E Hedlund, A Wyss, T Kainu, M Backlund, C Köhler, M Pelto-Huikko, J A Gustafsson and M WarnerMolecular Pharmacology August 1996, 50 (2) 342-350;
Perno, C F
- You have accessPotent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.C F Perno, E Balestra, S Aquaro, S Panti, A Cenci, G Lazzarino, B Tavazzi, D Di Pierro, J Balzarini and R CalioMolecular Pharmacology August 1996, 50 (2) 359-366;
- You have accessHighly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.J Balzarini, H Pelemans, S Aquaro, C F Perno, M Witvrouw, D Schols, E De Clercq and A KarlssonMolecular Pharmacology August 1996, 50 (2) 394-401;
Polonsky, K S
- You have accessLeptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus.S R Glaum, M Hara, V P Bindokas, C C Lee, K S Polonsky, G I Bell and R J MillerMolecular Pharmacology August 1996, 50 (2) 230-235;
Poyner, D R
- You have accessA nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.J M Coulson, D R Poyner, A Chantry, W J Irwin and S AkhtarMolecular Pharmacology August 1996, 50 (2) 314-325;
Pratt, D S
- You have accessIdentification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.F Schmitz, D S Pratt, M J Wu, L F Kolakowski, M Beinborn and A S KopinMolecular Pharmacology August 1996, 50 (2) 436-441;
Pulaski, J T
- You have accessAttenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.Y J Jeon, K H Yang, J T Pulaski and N E KaminskiMolecular Pharmacology August 1996, 50 (2) 334-341;
R
Rabkin, S D
- You have accessTreatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.T Yazaki, S Ahmad, A Chahlavi, E Zylber-Katz, N M Dean, S D Rabkin, R L Martuza and R I GlazerMolecular Pharmacology August 1996, 50 (2) 236-242;
Ramamoorthy, S
- You have accessInability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.H E Melikian, S Ramamoorthy, C G Tate and R D BlakelyMolecular Pharmacology August 1996, 50 (2) 266-276;
Robbins, J D
- You have accessIrreversible inhibition of forskolin interactions with type I adenylyl cyclase by a 6-isothiocyanate derivative of forskolin.E M Sutkowski, J D Robbins, W J Tang and K B SeamonMolecular Pharmacology August 1996, 50 (2) 299-305;
Rossi, G C
- You have accessDifferential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits.K M Standifer, G C Rossi and G W PasternakMolecular Pharmacology August 1996, 50 (2) 293-298;
Roth, B L
- You have accessRapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro.S A Berry, M C Shah, N Khan and B L RothMolecular Pharmacology August 1996, 50 (2) 306-313;
Rudolf, K
- You have accessNeuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.M Sautel, K Rudolf, H Wittneben, H Herzog, R Martinez, M Munoz, W Eberlein, W Engel, P Walker and A G Beck-SickingerMolecular Pharmacology August 1996, 50 (2) 285-292;
S
Sautel, M
- You have accessNeuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.M Sautel, K Rudolf, H Wittneben, H Herzog, R Martinez, M Munoz, W Eberlein, W Engel, P Walker and A G Beck-SickingerMolecular Pharmacology August 1996, 50 (2) 285-292;
Schmitz, F
- You have accessIdentification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.F Schmitz, D S Pratt, M J Wu, L F Kolakowski, M Beinborn and A S KopinMolecular Pharmacology August 1996, 50 (2) 436-441;
Schofield, P R
- You have accessA single amino acid determines differences in ethanol actions on strychnine-sensitive glycine receptors.M P Mascia, S J Mihic, C F Valenzuela, P R Schofield and R A HarrisMolecular Pharmacology August 1996, 50 (2) 402-406;
Schols, D
- You have accessHighly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.J Balzarini, H Pelemans, S Aquaro, C F Perno, M Witvrouw, D Schols, E De Clercq and A KarlssonMolecular Pharmacology August 1996, 50 (2) 394-401;
Scribner, M K
- You have accessStructural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region.S M Wade, M K Scribner, H M Dalman, J M Taylor and R R NeubigMolecular Pharmacology August 1996, 50 (2) 351-358;
Seamon, K B
- You have accessIrreversible inhibition of forskolin interactions with type I adenylyl cyclase by a 6-isothiocyanate derivative of forskolin.E M Sutkowski, J D Robbins, W J Tang and K B SeamonMolecular Pharmacology August 1996, 50 (2) 299-305;
Séguéla, P
- You have accessDifferential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels.I Bouchelet, Z Cohen, B Case, P Séguéla and E HamelMolecular Pharmacology August 1996, 50 (2) 219-223;
Shah, M C
- You have accessRapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro.S A Berry, M C Shah, N Khan and B L RothMolecular Pharmacology August 1996, 50 (2) 306-313;
Simon, J
- You have accessA novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates.T E Webb, D Henderson, B F King, S Wang, J Simon, A N Bateson, G Burnstock and E A BarnardMolecular Pharmacology August 1996, 50 (2) 258-265;
Standifer, K M
- You have accessDifferential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits.K M Standifer, G C Rossi and G W PasternakMolecular Pharmacology August 1996, 50 (2) 293-298;
Sutkowski, E M
- You have accessIrreversible inhibition of forskolin interactions with type I adenylyl cyclase by a 6-isothiocyanate derivative of forskolin.E M Sutkowski, J D Robbins, W J Tang and K B SeamonMolecular Pharmacology August 1996, 50 (2) 299-305;
T
Tang, W J
- You have accessIrreversible inhibition of forskolin interactions with type I adenylyl cyclase by a 6-isothiocyanate derivative of forskolin.E M Sutkowski, J D Robbins, W J Tang and K B SeamonMolecular Pharmacology August 1996, 50 (2) 299-305;
Tate, C G
- You have accessInability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.H E Melikian, S Ramamoorthy, C G Tate and R D BlakelyMolecular Pharmacology August 1996, 50 (2) 266-276;
Tavazzi, B
- You have accessPotent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.C F Perno, E Balestra, S Aquaro, S Panti, A Cenci, G Lazzarino, B Tavazzi, D Di Pierro, J Balzarini and R CalioMolecular Pharmacology August 1996, 50 (2) 359-366;
Taylor, J M
- You have accessStructural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region.S M Wade, M K Scribner, H M Dalman, J M Taylor and R R NeubigMolecular Pharmacology August 1996, 50 (2) 351-358;
Trueba, M
- You have accessThrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.F J Azula, E S Alzola, M Conde, M Trueba, J M Macarulla and A MarinoMolecular Pharmacology August 1996, 50 (2) 367-379;
Tseng, C P
- You have accessInhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity by genistein, a tyrosine kinase inhibitor.C P Tseng and A K VermaMolecular Pharmacology August 1996, 50 (2) 249-257;
V
Valenzuela, C F
- You have accessA single amino acid determines differences in ethanol actions on strychnine-sensitive glycine receptors.M P Mascia, S J Mihic, C F Valenzuela, P R Schofield and R A HarrisMolecular Pharmacology August 1996, 50 (2) 402-406;
Van Koppen, C J
- You have accessReceptor internalization delays m4 muscarinic acetylcholine receptor resensitization at the plasma membrane.G S Bogatkewitsch, W Lenz, K H Jakobs and C J Van KoppenMolecular Pharmacology August 1996, 50 (2) 424-429;
Verma, A K
- You have accessInhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity by genistein, a tyrosine kinase inhibitor.C P Tseng and A K VermaMolecular Pharmacology August 1996, 50 (2) 249-257;
W
Wade, S M
- You have accessStructural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region.S M Wade, M K Scribner, H M Dalman, J M Taylor and R R NeubigMolecular Pharmacology August 1996, 50 (2) 351-358;
Walker, P
- You have accessNeuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.M Sautel, K Rudolf, H Wittneben, H Herzog, R Martinez, M Munoz, W Eberlein, W Engel, P Walker and A G Beck-SickingerMolecular Pharmacology August 1996, 50 (2) 285-292;
Wang, S
- You have accessA novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates.T E Webb, D Henderson, B F King, S Wang, J Simon, A N Bateson, G Burnstock and E A BarnardMolecular Pharmacology August 1996, 50 (2) 258-265;
Warner, M
- You have accessCytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene.E Hedlund, A Wyss, T Kainu, M Backlund, C Köhler, M Pelto-Huikko, J A Gustafsson and M WarnerMolecular Pharmacology August 1996, 50 (2) 342-350;
Watt, W C
- You have accessUridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.R A Nicholas, W C Watt, E R Lazarowski, Q Li and K HardenMolecular Pharmacology August 1996, 50 (2) 224-229;
Webb, T E
- You have accessA novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates.T E Webb, D Henderson, B F King, S Wang, J Simon, A N Bateson, G Burnstock and E A BarnardMolecular Pharmacology August 1996, 50 (2) 258-265;
Wible, B
- You have accessMapping the block of a cloned human inward rectifier potassium channel by dofetilide.J Kiehn, B Wible, A E Lacerda and A M BrownMolecular Pharmacology August 1996, 50 (2) 380-387;
Wittneben, H
- You have accessNeuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.M Sautel, K Rudolf, H Wittneben, H Herzog, R Martinez, M Munoz, W Eberlein, W Engel, P Walker and A G Beck-SickingerMolecular Pharmacology August 1996, 50 (2) 285-292;
Witvrouw, M
- You have accessHighly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.J Balzarini, H Pelemans, S Aquaro, C F Perno, M Witvrouw, D Schols, E De Clercq and A KarlssonMolecular Pharmacology August 1996, 50 (2) 394-401;
Wu, M J
- You have accessIdentification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.F Schmitz, D S Pratt, M J Wu, L F Kolakowski, M Beinborn and A S KopinMolecular Pharmacology August 1996, 50 (2) 436-441;
Wyss, A
- You have accessCytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene.E Hedlund, A Wyss, T Kainu, M Backlund, C Köhler, M Pelto-Huikko, J A Gustafsson and M WarnerMolecular Pharmacology August 1996, 50 (2) 342-350;
Y
Yang, K H
- You have accessAttenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.Y J Jeon, K H Yang, J T Pulaski and N E KaminskiMolecular Pharmacology August 1996, 50 (2) 334-341;
Yao, S Y
- You have accessTransport of the antiviral nucleoside analogs 3'-azido-3'-deoxythymidine and 2',3'-dideoxycytidine by a recombinant nucleoside transporter (rCNT) expressed in Xenopus laevis oocytes.S Y Yao, C E Cass and J D YoungMolecular Pharmacology August 1996, 50 (2) 388-393;
Yazaki, T
- You have accessTreatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.T Yazaki, S Ahmad, A Chahlavi, E Zylber-Katz, N M Dean, S D Rabkin, R L Martuza and R I GlazerMolecular Pharmacology August 1996, 50 (2) 236-242;
Young, J D
- You have accessTransport of the antiviral nucleoside analogs 3'-azido-3'-deoxythymidine and 2',3'-dideoxycytidine by a recombinant nucleoside transporter (rCNT) expressed in Xenopus laevis oocytes.S Y Yao, C E Cass and J D YoungMolecular Pharmacology August 1996, 50 (2) 388-393;
Z
Zylber-Katz, E
- You have accessTreatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.T Yazaki, S Ahmad, A Chahlavi, E Zylber-Katz, N M Dean, S D Rabkin, R L Martuza and R I GlazerMolecular Pharmacology August 1996, 50 (2) 236-242;
In this issue

Advertisement